IREDA board approves raising Rs 5000 crore via QIP

Key renewable power play IREDA board has approved raising Rs 5000 crore through a QIP or qualified institutions placement in one or more tranches. The filing at the exchanges specified that the board has decided that fund raising is subject to shareholder approval and Govt shareholding will not decirease more than 7% of the company’s post-issue paid-up equity share capital.

The funds raised are expected to be used to support demand for green energy financing. It will be put to use to scale up support for clean energy financing initiatives in the country.

IREDA raised Rs 4500 cr via QIP in September, 2024

This is second approval from the Indian Renewable Energy Development Agency board for raising funds via QIP in a span of less than 6 months. The board had earlier approved raising up to Rs 4,500 crore through another QIP in September last yea. DIPAM (The Department of Investment and Public Asset Management) approved this fresh equity issue.

Why did IREDA chose to raise funds via QIP

QIP or qualified institutions placement is an instrument to raise funds. Companies use it to raise funds via qualified institutional buyers. Some of the key advantages of this kind of fund raising initiative include lower transaction costs,  better pricing, and access to exclusive deals. However, it is dependent on market rates and runs the risk of underpricing depending on market conditions.

IREDA stock Vs Nifty

The IREDA stock ended Thusday’s session down 2%. It had slumped to intrad-day low of Rs 195.29, down 3% before recovering some ground in late trade. The stock hit a 52-week low of Rs 121 on March, 2024 while it hits its 52-week high on July last year. The stock is down over 5% in 5 days and a whopping 24% in last 6 months. However, over 1 year time-frame it has delivered 27% plus returns to investors.

In the same period if we compare the stock to Nifty’s performance, Nifty gave investors 9% returns over 1 year while over 6 months, the benchmark Index deliveed negative returns of 5%.

 » Read More

Related Articles

Mphasis posts modest revenue, profit growth in Q3

Mphasis reported a sequential revenue growth of 0.8% to Rs 3,561.3 crore and a net profit of Rs 427.9 crore, up 1.1%, for the quarter ended December.  “We continue to stay focused on driving deal activity and closures, as we get on the other side of the macro cycle. AI is driving a fundamental shift

Q3FY25 Results: Thyrocare reports 30 percent rise in profit; Revenue stood at Rs 165.9 Crore

Thyrocare on Thursday announced its financial results for the quarter and nine months ended December 31, 2024. According to the company’s statement, the diagnostics major reported revenue of Rs. 165.9 Cr in Q3FY25 with a growth of 23 percent YoY. According to the company’s statement, Thyrocare’s consolidated revenue increased by 23% year-over-year (YoY) with Pathology

Gold prices soar to new peak of Rs 82,900 per 10 gm; silver drops by Rs 500

Gold prices rose Rs 170 to hit a fresh record high of Rs 82,900 per 10 grams in the national capital on Thursday amid a positive global trend, according to the All India Sarafa Association. The precious metal had closed at Rs 82,730 per 10 grams on Wednesday. In about one year, the precious metal

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Stay Connected

0FansLike
0FollowersFollow
0SubscribersSubscribe
- Advertisement -

Latest Articles

Mphasis posts modest revenue, profit growth in Q3

Mphasis reported a sequential revenue growth of 0.8% to Rs 3,561.3 crore and a net profit of Rs 427.9 crore, up 1.1%, for the quarter ended December.  “We continue to stay focused on driving deal activity and closures, as we get on the other side of the macro cycle. AI is driving a fundamental shift

Q3FY25 Results: Thyrocare reports 30 percent rise in profit; Revenue stood at Rs 165.9 Crore

Thyrocare on Thursday announced its financial results for the quarter and nine months ended December 31, 2024. According to the company’s statement, the diagnostics major reported revenue of Rs. 165.9 Cr in Q3FY25 with a growth of 23 percent YoY. According to the company’s statement, Thyrocare’s consolidated revenue increased by 23% year-over-year (YoY) with Pathology

Gold prices soar to new peak of Rs 82,900 per 10 gm; silver drops by Rs 500

Gold prices rose Rs 170 to hit a fresh record high of Rs 82,900 per 10 grams in the national capital on Thursday amid a positive global trend, according to the All India Sarafa Association. The precious metal had closed at Rs 82,730 per 10 grams on Wednesday. In about one year, the precious metal

Good news for taxpayers! Govt removes THESE difficulties to ensure more tax cases are settled – Check details!

Good news for taxpayers! The Finance Ministry has made some changes to the Direct Tax Vivad Se Vishwas Scheme, 2024, removing “difficulties” that arose due to certain situations for taxpayers. This update in the scheme will bring relief to taxpayers who wanted to apply for the scheme but could not do so earlier. “CBDT…makes the

Johnnie Walker-maker United Spirits posts Q3 profit decline of 4.29% to Rs 335 crore, revenue up 11.06% YoY

United Spirits, which makes Smirnoff vodka, on Thursday reported a profit of Rs 335 crore for the third quarter of FY25, posting a decline of 4.29 per cent in comparison to Rs 350 crore during the corresponding quarter of previous financial year. It posted revenue from operations at Rs 7,732 crore, reporting a growth of